Title: POS-480 MYCOPHENOLATE MOFETIL IN TREATMENT OF ADULT ONSET MINIMAL CHANGE DISEASE: OUTCOMES OF A TUNISIAN STUDY
Abstract: Mycophenolate mofetil (MMF) is considered to be less effective than calcineurin inhibitors in the treatment of minimal change disease (MCD), but some studies have shown its comparable efficacy in patient not responding to corticosteroids with better tolerance than calcineurin inhibitors.The aim of this study is to describe the characteristics and outcomes of patients with MCD treated with MMF.
Publication Year: 2022
Publication Date: 2022-02-01
Language: en
Type: article
Indexed In: ['crossref']
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot